Aspen Aerogels (NYSE:ASPN) Trading Down 9.3% After Analyst Downgrade

Aspen Aerogels, Inc. (NYSE:ASPN) traded down 9.3% on Tuesday after Barclays lowered their price target on the stock from $27.00 to $25.00. Barclays currently has an overweight rating on the stock. Aspen Aerogels traded as low as $15.63 and last traded at $15.66. 1,418,163 shares traded hands during mid-day trading, a decline of 10% from the average session volume of 1,572,187 shares. The stock had previously closed at $17.26.

Other research analysts also recently issued reports about the company. TD Cowen raised their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Thursday, October 31st. HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Piper Sandler cut their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Roth Mkm cut their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $28.70.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at $626,610.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Oppenheimer & Co. Inc. acquired a new stake in Aspen Aerogels during the 1st quarter worth about $388,000. Dakota Wealth Management acquired a new stake in Aspen Aerogels during the 3rd quarter worth about $986,000. Rice Hall James & Associates LLC lifted its position in Aspen Aerogels by 19.9% during the 3rd quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock worth $14,817,000 after acquiring an additional 88,711 shares during the period. Comerica Bank acquired a new stake in Aspen Aerogels during the 1st quarter worth about $1,992,000. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its position in Aspen Aerogels by 66.7% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock worth $1,922,000 after acquiring an additional 32,243 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 1.6 %

The stock has a 50-day simple moving average of $22.66 and a 200 day simple moving average of $24.74. The company has a market cap of $1.28 billion, a price-to-earnings ratio of 1,555.56 and a beta of 2.21. The company has a current ratio of 2.93, a quick ratio of 2.82 and a debt-to-equity ratio of 0.27.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.